11.66

2.83% -0.34

Bicycle Therapeutics Plc Adr (BCYC)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$12.00

Offen:

$12.05

24-Stunden-Volumen:

488.86K

Relative Volume:

1.03

Marktkapitalisierung:

$805.08M

Einnahmen:

$36.90M

Nettoeinkommen (Verlust:

$-166.28M

KGV:

-3.5441

EPS:

-3.29

Netto-Cashflow:

$-203.53M

1W Leistung:

-7.09%

1M Leistung:

-14.01%

6M Leistung:

-48.25%

1J Leistung:

-49.74%

1-Tages-Spanne:

$11.62

$12.61

1-Wochen-Bereich:

$11.62

$13.11

52-Wochen-Spanne:

$11.14

$28.67

Bicycle Therapeutics Plc Adr Stock (BCYC) Company Profile

Firmenname

Bicycle Therapeutics Plc Adr

Sektor

Healthcare (1169)

Branche

Biotechnology (678)

Telefon

011441223261503

Adresse

BLOCKS A & B, PORTWAY BUILDING, CAMBRIDGE

Mitarbeiter

284

Twitter

@Bicycle_tx

Nächster Verdiensttermin

2024-10-31

Neueste SEC-Einreichungen

BCYC's Discussions on Twitter

Vergleichen Sie BCYC mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
BCYC Bicycle Therapeutics Plc Adr	11.66	805.08M	36.90M	-166.28M	-203.53M	-3.29
VRTX Vertex Pharmaceuticals Inc	484.24	124.35B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	700.33	76.56B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	644.48	39.16B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	250.59	32.44B	2.25B	-278.16M	-42.59M	-2.17
BNTX Biontech Se Adr	120.01	28.77B	3.30B	-501.07M	1.03B	-2.1146

Bicycle Therapeutics Plc Adr Stock (BCYC) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-11-08	Eingeleitet	Stephens	Equal-Weight
2024-09-06	Eingeleitet	RBC Capital Mkts	Outperform
2024-08-07	Herabstufung	B. Riley Securities	Buy → Neutral
2023-09-11	Hochstufung	B. Riley Securities	Neutral → Buy
2022-08-31	Eingeleitet	Cowen	Outperform
2022-07-28	Eingeleitet	Barclays	Overweight
2022-07-06	Fortgesetzt	Canaccord Genuity	Buy
2022-04-13	Herabstufung	B. Riley Securities	Buy → Neutral
2022-04-07	Fortgesetzt	Cantor Fitzgerald	Overweight
2022-02-14	Eingeleitet	Morgan Stanley	Equal-Weight
2021-12-17	Eingeleitet	SVB Leerink	Outperform
2021-12-09	Eingeleitet	Needham	Buy
2021-09-30	Eingeleitet	B. Riley Securities	Buy
2021-04-20	Eingeleitet	JMP Securities	Mkt Outperform
2020-10-12	Eingeleitet	Cantor Fitzgerald	Overweight
2020-06-12	Eingeleitet	Oppenheimer	Outperform
2020-04-17	Eingeleitet	H.C. Wainwright	Buy
2019-11-14	Eingeleitet	ROTH Capital	Buy
2019-09-11	Hochstufung	Goldman	Neutral → Buy
2019-06-17	Eingeleitet	Canaccord Genuity	Buy
2019-06-17	Eingeleitet	Goldman	Neutral
2019-06-17	Eingeleitet	Jefferies	Buy
2019-06-17	Eingeleitet	Piper Jaffray	Overweight

Alle ansehen

Bicycle Therapeutics Plc Adr Aktie (BCYC) Neueste Nachrichten

Jan 15, 2025

Bicycle Therapeutics' SWOT analysis: platform potential drives stock outlook - Investing.com India

Jan 15, 2025

Jan 13, 2025

Bicycle Therapeutics reports promising cancer drug trial results - Investing.com India

Jan 13, 2025

Jan 07, 2025

Bicycle therapeutics CDO Santiago Arroyo sells shares worth $69,646 - Investing.com India

Jan 07, 2025

Jan 06, 2025

Bicycle Therapeutics CFO Alethia Young sells shares totaling $19,655 - Investing.com

Jan 06, 2025

Bicycle Therapeutics exec sells $30k in shares - Investing.com

Jan 06, 2025

Bicycle Therapeutics CAO Travis Thompson sells $67,292 in shares By Investing.com - Investing.com South Africa

Jan 06, 2025

Bicycle Therapeutics CTO sells shares worth $60,119 By Investing.com - Investing.com South Africa

Jan 06, 2025

Bicycle Therapeutics CAO Travis Thompson sells $67,292 in shares - Investing.com

Jan 06, 2025

Bicycle Therapeutics CEO Lee sells shares worth $172,952 By Investing.com - Investing.com South Africa

Jan 06, 2025

Bicycle Therapeutics CEO Lee sells shares worth $172,952 - Investing.com India

Jan 06, 2025

Dec 19, 2024

Bicycle Therapeutics' SWOT analysis: stock outlook amid clinical trials and cash strength - Investing.com India

Dec 19, 2024

Dec 14, 2024

Bicycle Therapeutics' SWOT analysis: stock's potential rides on clinical data By Investing.com - Investing.com South Africa

Dec 14, 2024

Bicycle Therapeutics' SWOT analysis: stock's potential rides on clinical data - Investing.com

Dec 14, 2024

Dec 09, 2024

FDA Accepts GSK's Filing for Expanded Use of Nucala in COPD - Yahoo Finance

Dec 09, 2024

Nov 27, 2024

ALEC Stock Tanks as Alzheimer's Drug Fails in Mid-Stage Study - Yahoo Finance

Nov 27, 2024

Nov 25, 2024

Pharmacovigilance and Drug Safety Software Market Size to Reach USD 371.88 Million by 2032, Growing at a 6.76% CAGR – SNS Insider - Yahoo Finance

Nov 25, 2024

Nov 21, 2024

SAGE's Dalzanemdor Fails to Meet Goal in Huntington's Disease Study - Yahoo Finance

Nov 21, 2024

Nov 19, 2024

ALDX Up as FDA Accepts Resubmitted NDA for Eye Drug Reproxalap - Yahoo Finance

Nov 19, 2024

Nov 15, 2024

Merck Inks $3.3B Licensing Deal With Chinese Biotech for Cancer Therapy - Yahoo Finance

Nov 15, 2024

Nov 13, 2024

Bicycle Therapeutics' SWOT analysis: innovative platform fuels stock's potential - Investing.com India

Nov 13, 2024

Bicycle Therapeutics' chief accounting officer sells shares worth $157,113 - Investing.com

Nov 13, 2024

Nov 02, 2024

Bicycle Therapeutics Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Nov 02, 2024

Oct 31, 2024

Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results - Yahoo Finance

Oct 31, 2024

Oct 28, 2024

Bicycle Therapeutics' SWOT analysis: stock's potential rides on innovative platform - Investing.com India

Oct 28, 2024

Oct 24, 2024

Bicycle Therapeutics retains stock target and Buy rating on promising data - Investing.com

Oct 24, 2024

Oct 23, 2024

Bicycle Therapeutics spotlights cancer treatment targets - Investing.com

Oct 23, 2024

Oct 21, 2024

Novartis Gets CHMP Recommendation for Kisqali in Broader Population - Yahoo Finance

Oct 21, 2024

Oct 19, 2024

Bicycle Therapeutics (BCYC) Soars 5.7%: Is Further Upside Left in the Stock? - MSN

Oct 19, 2024

Oct 14, 2024

A company insider recently sold 3,212 shares of Bicycle Therapeutics Plc ADR [BCYC]. Should You also Consider to Sale? – Knox Daily - Knox Daily

Oct 14, 2024

Oct 10, 2024

BCYC’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - The InvestChronicle

Oct 10, 2024

Oct 08, 2024

Keeping an Eye on Bicycle Therapeutics Plc ADR (BCYC) After Insider Trading Activity - Knox Daily

Oct 08, 2024